APA (7th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. (2016). CADTH Canadian Drug Expert Committee final recommendation Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication: Type 2 diabetes. Canadian Agency for Drugs and Technologies in Health.

Chicago Style (17th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Final Recommendation Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) Indication: Type 2 Diabetes. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2016.

MLA (9th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Final Recommendation Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) Indication: Type 2 Diabetes. Canadian Agency for Drugs and Technologies in Health, 2016.

Warning: These citations may not always be 100% accurate.